USANA Health Sciences, Inc.
USNA
$14.96
$0.533.67%
NYSE
| 07/04/2026 | 04/04/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -10.77% | 10.62% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -10.77% | 10.62% | |||
| Cost of Revenue | -18.67% | 20.30% | |||
| Gross Profit | -8.31% | 7.91% | |||
| SG&A Expenses | -6.28% | 10.88% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -9.40% | 13.11% | |||
| Operating Income | -34.11% | -19.57% | |||
| Income Before Tax | -222.21% | 270.24% | |||
| Income Tax Expenses | 6.41% | 47.37% | |||
| Earnings from Continuing Operations | -501.65% | 536.30% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 1,081.47% | 408.89% | |||
| Net Income | -384.52% | 523.38% | |||
| EBIT | -34.11% | -19.57% | |||
| EBITDA | -24.09% | -14.18% | |||
| EPS Basic | -383.16% | 521.13% | |||
| Normalized Basic EPS | 26.26% | -6.05% | |||
| EPS Diluted | -383.97% | 521.13% | |||
| Normalized Diluted EPS | 26.35% | -6.12% | |||
| Average Basic Shares Outstanding | 0.48% | 0.52% | |||
| Average Diluted Shares Outstanding | 0.41% | 0.60% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||